| |
Disease-specific survival
|
Disease-free survival
|
|---|
|
Characteristics
|
HR (95 % CI)
|
p-value
|
HR (95 % CI)
|
p-value
|
|---|
|
Performance status
|
|
0
|
1
|
<0.001*
|
1
|
<0.001*
|
|
≥ 1
|
8.72 (2.76–27.59)
| |
5.31 (2.40–11.78)
| |
|
Radiation dose
|
|
≤ 50 Gy
|
1
| |
1
|
0.618
|
|
> 50 Gy
|
2.15 (0.46–10.07)
|
0.331
|
1.31 (0.45–3.81)
| |
|
Endoscopic resection
|
|
No
|
1
|
0.268
|
1
|
0.656
|
|
Yes
|
2.67 (0.47–15.20)
| |
1.31 (0.40–4.30)
| |
|
Chemotherapy
|
|
No
|
1
|
0.032
|
1
|
0.184
|
|
Yes
|
0.29 (0.092–0.90)
| |
0.59 (0.27–1.29)
| |
-
HR hazard ratio, CI confidential interval, ENI elective nodal irradiation, RT radiotherapy. *Indicates significance after adjustment with Bonferroni correction (p-value < 0.0125)
